ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,206Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 559

$761K Total Retail Price of All Prescriptions

Rank: 10 out of 559

693 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 693 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 693 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 771 602 1 2
LISINOPRIL 675 559 2 1
SIMVASTATIN 511 433 3 3
OMEPRAZOLE 501 345 4 4
AMLODIPINE BESYLATE 457 381 5 6
METFORMIN HCL 364 267 6 5
FUROSEMIDE 333 271 7 11
HYDROCODONE-ACETAMINOPHEN 265 162 S3 8 7
WARFARIN SODIUM 257 228 9 24
POTASSIUM CHLORIDE 237 179 10 23
JANUVIA 228 189 11 50
DONEPEZIL HCL 224 205 12 36
GABAPENTIN 197 115 13 9
CITALOPRAM HBR 190 149 14 21
PREDNISONE 188 143 15 49
HYDROCHLOROTHIAZIDE 162 119 16 8
ALENDRONATE SODIUM 161 129 17 13
TRAMADOL HCL 161 113 17 27
SERTRALINE HCL 152 103 19 19
LOSARTAN POTASSIUM 152 134 19 14
TAMSULOSIN HCL 149 140 21 25
METOPROLOL TARTRATE 136 120 22 12
RANITIDINE HCL 132 58 23 26
ZOLPIDEM TARTRATE 129 61 24 17
ATORVASTATIN CALCIUM 123 110 25 20
NAMENDA 116 116 26 56
NEXIUM 109 96 27 57
ZOSTAVAX 109 91 27 151
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 80 29 18
MIRTAZAPINE 104 103 30 61
METOPROLOL SUCCINATE 104 89 30 16
LOVASTATIN 103 80 32 10
ATENOLOL 102 81 33 15
MELOXICAM 93 83 34 42
AZITHROMYCIN 92 67 35 39
ESCITALOPRAM OXALATE 91 68 36 109
CYMBALTA 89 44 37 78
CLONIDINE HCL 89 86 37 68
OXYCODONE HCL 86 23 S2 39 32
SPIRONOLACTONE 86 69 39 74
RISPERIDONE 84 77 41 91
CIPROFLOXACIN HCL 83 73 42 60
DIGOXIN 81 80 43 94
GEMFIBROZIL 77 62 44 71
DIOVAN 77 76 44 55
ADVAIR DISKUS 76 63 46 46
LANTUS 74 64 47 40
TRIAMTERENE-HCTZ 74 61 47 47
PAROXETINE HCL 73 59 49 48
ROPINIROLE HCL 71 64 50 95
SPIRIVA 71 64 50 67
TRAZODONE HCL 70 55 52 28
KLOR-CON M10 69 51 53 140
OXYBUTYNIN CHLORIDE 68 31 54 62
FLUOXETINE HCL 67 46 55 37
PROAIR HFA 64 39 56 29
NOVOLOG 63 48 57 155
BENICAR 61 56 58 170
CLOPIDOGREL 61 40 58 51
LANTUS SOLOSTAR 61 54 58 136
ALLOPURINOL 59 48 61 34
KLOR-CON 10 56 37 62 141
KLOR-CON M20 55 50 63 103
PREMARIN 54 33 R 64 97
BACLOFEN 53 15 65 90
PEN NEEDLE 52 46 66 150
CARVEDILOL 52 45 66 38
SINGULAIR 50 34 68 130
OXYCODONE-ACETAMINOPHEN 50 37 S2 68 44
GLYBURIDE 50 38 R 68 45
PRAVASTATIN SODIUM 50 46 68 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.